New PET/MR scan could spot nerve amyloid without a biopsy
NCT ID NCT03019029
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a special PET/MR scan using a radioactive tracer called F-18 florbetapir can detect amyloid protein buildup in the nerves of people with amyloidosis. Eight adults with confirmed nerve amyloidosis or other nerve diseases took part. The goal was to see if the scan could tell the difference between amyloid and non-amyloid nerve problems.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 18-F Florbetapir (a radioactive tracer used in PET scans)
- What this could lead to
- If successful, this scan could become a new way to diagnose nerve amyloidosis without needing a biopsy.
- What could go wrong
- This was a very small, early-phase study with only 8 participants. The results may not apply to everyone, and the scan is not yet a standard test.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A hidden warning in your wrist? surgery may reveal heart risk
- Can a daily pill keep a rare heart disease in check for the long haul?
- Heart drug acoramidis tested for Long-Term cardiac repair in rare amyloidosis
- App-Based diet tracking tested in rare disease
- Hidden amyloid in heart valves: a new clue in aortic stenosis?
- New nerve patch could ease pain after biopsy